Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.

Míreanna comhchosúla

• Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012
  de réir: Reilly, J, et al.
  Foilsithe / Cruthaithe: (2014)
• Guideline for the diagnosis and management of myelofibrosis.
  de réir: Reilly, J, et al.
  Foilsithe / Cruthaithe: (2012)
• Guideline for the diagnosis and management of myelofibrosis
  de réir: Reilly, J, et al.
  Foilsithe / Cruthaithe: (2012)
• Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
  de réir: McLornan, DP, et al.
  Foilsithe / Cruthaithe: (2023)
• Treatment and management of myelofibrosis in the era of JAK inhibitors
  de réir: Keohane C, et al.
  Foilsithe / Cruthaithe: (2013-08-01)